Business

January 31, 2014 11:43 AM

FDA accepts Salix’s latest new drug application

Salix Pharmaceuticals announced this week that the Food and Drug Administration has accepted its new drug application for Budesonide, a rectal foam used to treat patients with ulcerative colitis.

Related content

Suggested for you

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs